Impact of AIM-Bio
AIM–Bio will benefit society by helping to implement new technologies that will reduce the cost and increase the effectiveness, safety and accessibility of new biopharmaceutical products. DTU will establish new avenues of investigation and education based on biopharmaceutical products, and NC State will greatly increase its portfolio of short courses and its knowledge base in the areas of industrial biotechnology and sustainability.
As importantly, this program will create a lasting bond for international collaborations that will enable both DTU and NC State to pursue future grant opportunities in biopharmaceutical manufacturing. This will ultimately ensure the sustainability of this effort, which will benefit the universities, the two nations, the global biopharmaceutical community, and society at large.